 Establishment Labs Holdings Inc. ESTA the Company, a medical technology company focused on Womens Health initially in the breast aesthetics and reconstruction market today announced the pricing of its public offering of 2,285,714 common shares at 26.25 per share. The gross proceeds to Establishment Labs, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately 60.0 million. The offering is scheduled to close on February 3, 2020, subject to the satisfaction of customary closing conditions. 